MARKET

CLLS

CLLS

Cellectis
NASDAQ
1.830
-1.270
-40.97%
After Hours: 1.840 +0.01 +0.55% 17:30 09/14 EDT
OPEN
2.320
PREV CLOSE
3.100
HIGH
2.420
LOW
1.750
VOLUME
1.17M
TURNOVER
--
52 WEEK HIGH
5.48
52 WEEK LOW
1.750
MARKET CAP
133.04M
P/E (TTM)
-2.8154
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 7h ago
Crude Oil Jumps 3%; Corning Shares Move Lower
Benzinga · 8h ago
Nasdaq Down Over 200 Points; Cellectis Shares Plunge
Benzinga · 10h ago
Cellectis Pivots to Gene Editing in Major Overhaul
Benzinga · 10h ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 12h ago
Corning, Cellectis, Biodexa Pharmaceuticals And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
Benzinga · 12h ago
Why Scholar Rock Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Benzinga · 14h ago
Weekly Report: what happened at CLLS last week (0907-0911)?
Weekly Report · 14h ago
More
About CLLS
Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development, and commercialization of rational genome engineering technologies. The Company develops immunotherapies that aim to force the immune system to target and eradicate cancer cells. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid (DNA) matrices into Meganuclease Recombination Systems (MRS), used for gene excision, correction or replacement. Cellectis SA markets its technologies mainly for use in the research field, in pharmaceutical drug discovery programs, in the agronomics, bioproduction, and biotherapeutics fields. Cellectis SA operates several subsidiaries. The Company operates in France and the United States, among others.

Webull offers Cellectis SA (ADR) stock information, including NASDAQ: CLLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLLS stock methods without spending real money on the virtual paper trading platform.